UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$325.61K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 13, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$501.27
Aug 13, 2026
Close before public filing
$501.27
Aug 13, 2026
Return since public filing
-0.83%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 640 shares @ $508.76
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000120
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$6.08M
Buys / sales
0 / 12
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $221.29K |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $80.61K |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $485.48K |
| United Therapeutics Corp UTHR Current | Sale | Aug 13, 2026 | $325.61K |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $122.97K |
| United Therapeutics Corp UTHR | Exercise | Aug 13, 2026 | $0 |
| United Therapeutics Corp UTHR | Exercise | Aug 13, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $626.6K |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $665.24K |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $762.35K |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $849.84K |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $466.57K |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $101.98K |
| United Therapeutics Corp UTHR | Sale | Aug 13, 2026 | $81.78K |